OXFORD, United Kingdom and MARLBOROUGH, Mass., March 4, 2014 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology, today announced fourth quarter and full year 2013 financial results.
Help employers find you! Check out all the jobs and post your resume.
